Ankur Drugs & Pharma Ltd.
BSE: 531683 | Sector: Health care |
NSE: ANKURDRUGS | ISIN Code: INE238D01012 |
BSE 05:30 | 01 Jan | Ankur Drugs & Pharma Ltd |
NSE 05:30 | 01 Jan | Ankur Drugs & Pharma Ltd |
Ankur Drugs & Pharma Ltd. (ANKURDRUGS) - BULK DEALS
DATE | CLIENT NAME | EXCHANGE | TRANSACTION | QUANTITY | PRICE |
19-05-2011 | IFCI VENTURE CAPITAL FUND LTD | NSE | SELL | 177000 | 42.33 |
19-05-2011 | NEERA SONI | NSE | SELL | 28509 | 39.62 |
19-05-2011 | NEERA SONI | NSE | BUY | 112424 | 42.38 |
19-05-2011 | IFCI VENTURE CAPITAL FUND LTD | BSE | SELL | 123000 | 42.27 |
15-12-2010 | RASOI LTD. | NSE | SELL | 106050 | 80.48 |
02-12-2010 |
PAM PHARMACEUTICAL& ALLIED MACH INERYCO PVTLTD |
NSE | SELL | 105460 | 101.44 |
29-09-2010 | RAJU BHANDARI | BSE | BUY | 116826 | 130.32 |
18-08-2010 | PRIVATBANK IHAG ZURICH AG | BSE | BUY | 101087 | 122.97 |
18-08-2010 | PRIVATBANK IHAG ZURICH AG | NSE | BUY | 208913 | 122.76 |
17-08-2010 |
RKSV SECURITIES INDIA PRIVATE LIMIT ED |
BSE | SELL | 109677 | 120.44 |
17-08-2010 |
RKSV SECURITIES INDIA PRIVATE LIMIT ED |
BSE | BUY | 109677 | 120.62 |
17-08-2010 |
APNA GHAR HSG DEVELOPMENT FINANCE L IMITED |
BSE | SELL | 147811 | 117.88 |
17-08-2010 | HINDUSTAN COMPOSITIES LTD. | NSE | SELL | 203754 | 119.35 |
16-08-2010 | KARVY FINANCIAL SERVICES LIMITED | BSE | SELL | 228600 | 113.64 |
16-08-2010 | PRIVATBANK IHAG ZURICH AG | BSE | BUY | 256892 | 114.83 |
16-08-2010 | PRIVATBANK IHAG ZURICH AG | NSE | BUY | 504358 | 119.74 |
16-08-2010 |
M/S CELLO PEN & STATIONARY PVT. LTD |
NSE | SELL | 100000 | 114.08 |
16-08-2010 | BP FINTRADE PRIVATE LIMITED | NSE | BUY | 105615 | 112.57 |
16-08-2010 | M/S. EVEREST FLAVOURS LTD | NSE | SELL | 110955 | 116.73 |
16-08-2010 | PRIVATBANK IHAG ZURICH AG | NSE | BUY | 504358 | 119.74 |
Quick Links for Ankur Drugs & Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices